Clinical Trial Update: Oral Iohexol in the Management of Chylous Ascites After After Retroperitoneal or Extended Lymphadenectomy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating oral iohexol for management of chylous ascites after retroperitoneal or extended lymphadenectomy; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abdominal Neoplasms
• Chylous Ascites
• Pelvic Neoplasms
• Retroperitoneal Lymph Node Metastasis

Drugs mentioned

• IOHEXOL (IOHEXOL)

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Chylous Ascites, Abdominal Neoplasm | Phase 2 | Status: COMPLETED